Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group.

Frangoul H, Ames MM, Mosher RB, Reid JM, Krailo MD, Seibel NL, Shaw DW, Steinherz PG, Whitlock JA, Holcenberg JS
Clin Cancer Res. 1999 5 (12): 3956-62

PMID: 10632325

MeSH Terms (13)

Adolescent Adult Antineoplastic Agents Child Child, Preschool Drug Administration Schedule Female Follow-Up Studies Humans Infusions, Intravenous Male Neoplasm Recurrence, Local Topotecan

Connections (1)

This publication is referenced by other Labnodes entities: